PERTH, Australia – Australia will save nearly A$500 million (US$379 million) over the next four years due to a deal hammered out by the federal government and pharmaceutical industry stakeholders. Read More

SHANGHAI – Chinese vaccine developer Cansino Inc., of Tianjin, has received $65 million in a financing round led by Future Industry Investment Fund to hasten the development of its later-stage vaccines and get a new vaccine plant up and running. Read More

HONG KONG – In a nationwide effort to combat clinical trial data fabrication, China’s Supreme People’s Court and the CFDA have simultaneously proposed new actions and regulatory changes. Read More

A collaborative study by Chinese and U.S. researchers has for the first time identified a critical new regulator of tumor growth, metastasis and immune response, which they showed to be an effective therapeutic target for triple-negative breast cancers (TNBCs) and potentially other cancers resistant to conventional treatments. Read More

HONG KONG – Pharmaceutical companies around the world are eying the Thailand market as it is set to almost double in size over the next few years. Read More

Foresee Pharmaceuticals Co. Ltd., of Taipei, Taiwan, appointed Yisheng Lee chief medical officer, and David Lau senior vice president, NCE preclinical and clinical development. Lee will work on establishing Foresee’s strategies related to portfolio management, clinical trials, regulatory affairs, pharmacovigilance and risk management. Read More